Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2011 Aug 29;58(6):959–963. doi: 10.1002/pbc.23300

Table IV.

Growth hormone deficiency and mean BMD and BMAD ± SEM

Femoral neck Hip Spine
Patients
(n)		 BMD (g/cm2) Z-score BMD (g/cm2) Z-score BMD (g/cm2) Z-score
Treated 20 0.878 ± 0.033 −0.385 ± 0.273 0.970 ± 0.032 −0.365 ± 0.259 0.978 ± 0.027 −0.115 ± 0.255
Untreated 9 0.725 ± 0.034 −1.378 ± 0.342 0.803 ± 0.045 −1.533 ± 0.460 0.779 ± 0.036 −2.067 ± 0.429
   p-value* 0.01 0.043 0.006 0.025 0.000 0.000
Patients
(n) 		BMAD (g/cm3) Z-score BMAD (g/cm3) Z-score
Treated 20 0.168 ± 0.006 −0.130 ± 0.25 0.150 ± 0.004 0.248 ± 0.264
Untreated 9 0.157 ± 0.009 −0.706 ± 0.393 0.131 ± 0.007 −1.368 ± 0.418
   p-value* 0.33 0.22 0.015 0.002
*

Testing for equal mean in treated and untreated patients.